-
1
-
-
4344707522
-
Steroid receptors and cell cycle in normal mammary epithelium
-
Anderson E., and Clarke R.B. Steroid receptors and cell cycle in normal mammary epithelium. J. Mammary Gland Biol. Neoplasia 9 (2004) 3-13
-
(2004)
J. Mammary Gland Biol. Neoplasia
, vol.9
, pp. 3-13
-
-
Anderson, E.1
Clarke, R.B.2
-
2
-
-
0027076340
-
Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies
-
Berthon P., Pancino G., de Cremoux P., Roseto A., Gespach C., and Calvo F. Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies. In Vitro Cell. Dev. Biol. 28A (1992) 716-724
-
(1992)
In Vitro Cell. Dev. Biol.
, vol.28 A
, pp. 716-724
-
-
Berthon, P.1
Pancino, G.2
de Cremoux, P.3
Roseto, A.4
Gespach, C.5
Calvo, F.6
-
3
-
-
0031973426
-
Selective estrogen receptor modulators: an alternative to hormone replacement therapy
-
Bryant H.U., and Dere W.H. Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc. Soc. Exp. Biol. Med. 217 (1998) 45-52
-
(1998)
Proc. Soc. Exp. Biol. Med.
, vol.217
, pp. 45-52
-
-
Bryant, H.U.1
Dere, W.H.2
-
4
-
-
0037031851
-
The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase(JAK)/STAT signaling pathways
-
Burysek L., Syrovets T., and Simmet T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase(JAK)/STAT signaling pathways. J. Biol. Chem. 277 (2002) 33509-33517
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 33509-33517
-
-
Burysek, L.1
Syrovets, T.2
Simmet, T.3
-
5
-
-
0037830132
-
Influence of estrogen plus progestin on breast cancer and mammography in healthy post menopausal women: the Women's Health Initiative Randomized Trial
-
WHI Investigators
-
Chlebowski R.T., Hendrix S.L., Langer R.D., Stefanick M.L., Gass M., Lane D., Rodabough R.J., Gilligan M.A., Cyr M.G., Thomson C.A., Khandekar J., Petrovitch H., McTiernan A.;, and WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy post menopausal women: the Women's Health Initiative Randomized Trial. JAMA 289 (2003) 3243-3253
-
(2003)
JAMA
, vol.289
, pp. 3243-3253
-
-
Chlebowski, R.T.1
Hendrix, S.L.2
Langer, R.D.3
Stefanick, M.L.4
Gass, M.5
Lane, D.6
Rodabough, R.J.7
Gilligan, M.A.8
Cyr, M.G.9
Thomson, C.A.10
Khandekar, J.11
Petrovitch, H.12
McTiernan A.13
14
-
6
-
-
0037464769
-
Overview of the main outcomes in breast-cancer prevention trials
-
Cuzick J., Powles T., Veronesi U., Forbes J., Edwards R., Ashley S., and Boyle P. Overview of the main outcomes in breast-cancer prevention trials. Lancet 361 (2003) 296-300
-
(2003)
Lancet
, vol.361
, pp. 296-300
-
-
Cuzick, J.1
Powles, T.2
Veronesi, U.3
Forbes, J.4
Edwards, R.5
Ashley, S.6
Boyle, P.7
-
7
-
-
18844439114
-
Postmenopausal hormone therapy: from monkey glands to transdermal patches
-
Davis S.R., Dinatale I., Rivera-Woll L., and Davison S. Postmenopausal hormone therapy: from monkey glands to transdermal patches. J. Endocrinol. 185 (2005) 207-222
-
(2005)
J. Endocrinol.
, vol.185
, pp. 207-222
-
-
Davis, S.R.1
Dinatale, I.2
Rivera-Woll, L.3
Davison, S.4
-
8
-
-
0035912903
-
Tissue-specific expression of human ERalpha and ERbeta in male
-
Denger S., Reid G., Brand H., Kos M., and Gannon F. Tissue-specific expression of human ERalpha and ERbeta in male. Mol. Cell. Endocrinol. 178 (2001) 155-160
-
(2001)
Mol. Cell. Endocrinol.
, vol.178
, pp. 155-160
-
-
Denger, S.1
Reid, G.2
Brand, H.3
Kos, M.4
Gannon, F.5
-
9
-
-
0034127782
-
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity.
-
Dubey R.K., Jackson E.K., Gillespie D.G., Zacharia L.C., Imthum B., and Keller P.J. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 964-972
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 964-972
-
-
Dubey, R.K.1
Jackson, E.K.2
Gillespie, D.G.3
Zacharia, L.C.4
Imthum, B.5
Keller, P.J.6
-
10
-
-
0025369353
-
MTT colorimetric assay for testing macrophage cytotoxic activity in vitro
-
Ferrari M., Fornasiero M.C., and Isetta A.M. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J. Immunol. Methods 131 (1990) 165-172
-
(1990)
J. Immunol. Methods
, vol.131
, pp. 165-172
-
-
Ferrari, M.1
Fornasiero, M.C.2
Isetta, A.M.3
-
11
-
-
0035799531
-
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
-
Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., Laudano A., Gazit A., Levitzki A., Kraker A., and Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20 (2001) 2499-2513
-
(2001)
Oncogene
, vol.20
, pp. 2499-2513
-
-
Garcia, R.1
Bowman, T.L.2
Niu, G.3
Yu, H.4
Minton, S.5
Muro-Cacho, C.A.6
Cox, C.E.7
Falcone, R.8
Fairclough, R.9
Parsons, S.10
Laudano, A.11
Gazit, A.12
Levitzki, A.13
Kraker, A.14
Jove, R.15
-
12
-
-
12944272024
-
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
-
Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., and Kim J.D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4227-4232
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 4227-4232
-
-
Grandis, J.R.1
Drenning, S.D.2
Zeng, Q.3
Watkins, S.C.4
Melhem, M.F.5
Endo, S.6
Johnson, D.E.7
Huang, L.8
He, Y.9
Kim, J.D.10
-
13
-
-
0025100521
-
Primary culture of normal rat mammary epithelial cells within a basement membrane matrix II. Functional differentiation under serum-free conditions
-
Hahm H.A., Ip M.M., Darcy K., Black J.D., Shea W.K., Forczek S., Yoshimura M., and Oka T. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix II. Functional differentiation under serum-free conditions. In Vitro Cell. Dev. Biol. 26 (1990) 803-814
-
(1990)
In Vitro Cell. Dev. Biol.
, vol.26
, pp. 803-814
-
-
Hahm, H.A.1
Ip, M.M.2
Darcy, K.3
Black, J.D.4
Shea, W.K.5
Forczek, S.6
Yoshimura, M.7
Oka, T.8
-
14
-
-
0023882899
-
CGRP receptor in cultured vascular smooth muscle and endothelial cells
-
Hirata Y., Takagi Y., and Takata S. CGRP receptor in cultured vascular smooth muscle and endothelial cells. Biochem. Biophys. Res. Commun. 151 (1988) 1113-1121
-
(1988)
Biochem. Biophys. Res. Commun.
, vol.151
, pp. 1113-1121
-
-
Hirata, Y.1
Takagi, Y.2
Takata, S.3
-
15
-
-
0034681917
-
Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects
-
Hodges Y.K., Tung L., Yan X.D., Graham J.D., Horwitz K.B., and Horwitz L.D. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101 (2000) 1792-1798
-
(2000)
Circulation
, vol.101
, pp. 1792-1798
-
-
Hodges, Y.K.1
Tung, L.2
Yan, X.D.3
Graham, J.D.4
Horwitz, K.B.5
Horwitz, L.D.6
-
16
-
-
0030914164
-
Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
-
Iafrati M.D., Karas R.H., Aronovitz M., Kim S., Sullivan Jr. T.R., Lubahn D.B., O'Donnell Jr. T.F., Korach K.S., and Mendelsohn M.E. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3 (1997) 545-548
-
(1997)
Nat. Med.
, vol.3
, pp. 545-548
-
-
Iafrati, M.D.1
Karas, R.H.2
Aronovitz, M.3
Kim, S.4
Sullivan Jr., T.R.5
Lubahn, D.B.6
O'Donnell Jr., T.F.7
Korach, K.S.8
Mendelsohn, M.E.9
-
17
-
-
0029870305
-
Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells
-
Inoue S., Hoshino S., Miyoshi H., Akishita M., Hosoi T., Orimo H., and Ouchi Y. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 219 (1996) 766-772
-
(1996)
Biochem. Biophys. Res. Commun.
, vol.219
, pp. 766-772
-
-
Inoue, S.1
Hoshino, S.2
Miyoshi, H.3
Akishita, M.4
Hosoi, T.5
Orimo, H.6
Ouchi, Y.7
-
18
-
-
0034735859
-
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology
-
Katzenellenbogen B.S., Choi I., Delage-Mourroux R., Ediger T.R., Martini P.G., Montano M., Sun J., Weis K., and Katzenellenbogen J.A. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J. Steroid Biochem. Mol. Biol. 74 (2000) 279-285
-
(2000)
J. Steroid Biochem. Mol. Biol.
, vol.74
, pp. 279-285
-
-
Katzenellenbogen, B.S.1
Choi, I.2
Delage-Mourroux, R.3
Ediger, T.R.4
Martini, P.G.5
Montano, M.6
Sun, J.7
Weis, K.8
Katzenellenbogen, J.A.9
-
19
-
-
0023038662
-
Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA
-
Kindy M.S., and Sonenshein G.E. Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA. J. Biol. Chem. 261 (1986) 12865-12868
-
(1986)
J. Biol. Chem.
, vol.261
, pp. 12865-12868
-
-
Kindy, M.S.1
Sonenshein, G.E.2
-
21
-
-
0033630308
-
Serine/threonine phosphorylation in cytokine signal transduction
-
McCubrey J.A., May W.S., Duronio V., and Mufson A. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 14 (2000) 9-21
-
(2000)
Leukemia
, vol.14
, pp. 9-21
-
-
McCubrey, J.A.1
May, W.S.2
Duronio, V.3
Mufson, A.4
-
22
-
-
0141619266
-
Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells
-
Mori-Abe A., Tsutsumi S., Takahashi K., Toya M., Yoshida M., Du B., Kawagoe J., Nakahara K., Takahashi T., Ohmichi M., and Kurachi H. Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells. J. Endocrinol. 178 (2003) 417-426
-
(2003)
J. Endocrinol.
, vol.178
, pp. 417-426
-
-
Mori-Abe, A.1
Tsutsumi, S.2
Takahashi, K.3
Toya, M.4
Yoshida, M.5
Du, B.6
Kawagoe, J.7
Nakahara, K.8
Takahashi, T.9
Ohmichi, M.10
Kurachi, H.11
-
23
-
-
1842389534
-
Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein
-
Nilsson J., Sjolund M., Palmberg L., Thyberg J., and Heldin CH. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4418-4422
-
(1985)
Proc. Natl. Acad. Sci. U. S. A.
, vol.82
, pp. 4418-4422
-
-
Nilsson, J.1
Sjolund, M.2
Palmberg, L.3
Thyberg, J.4
Heldin, CH.5
-
24
-
-
0037205290
-
Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury
-
Pare G., Krust A., Karas R.H., Dupont S., Aronovitz M., Chambon P., and Mendelsohn M.E. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ. Res. 90 (2002) 1087-1092
-
(2002)
Circ. Res.
, vol.90
, pp. 1087-1092
-
-
Pare, G.1
Krust, A.2
Karas, R.H.3
Dupont, S.4
Aronovitz, M.5
Chambon, P.6
Mendelsohn, M.E.7
-
25
-
-
0034762203
-
The Raf/MEK/ERK pathway: new concepts of activation
-
Peyssonnaux C., and Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell. 93 (2001) 53-62
-
(2001)
Biol. Cell.
, vol.93
, pp. 53-62
-
-
Peyssonnaux, C.1
Eychene, A.2
-
26
-
-
0031903106
-
Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells
-
Somjen D., Kohen F., Jaffe A., Amir-Zaltsman Y., Knoll E., and Stern N. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 32 (1998) 39-45
-
(1998)
Hypertension
, vol.32
, pp. 39-45
-
-
Somjen, D.1
Kohen, F.2
Jaffe, A.3
Amir-Zaltsman, Y.4
Knoll, E.5
Stern, N.6
-
27
-
-
0033083820
-
Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?
-
Speirs V., Parkes A.T., Kerin M.J., Walton D.S., Carleton P.J., Fox J.N., and Atkin S.L. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?. Cancer Res. 59 (1999) 525-528
-
(1999)
Cancer Res.
, vol.59
, pp. 525-528
-
-
Speirs, V.1
Parkes, A.T.2
Kerin, M.J.3
Walton, D.S.4
Carleton, P.J.5
Fox, J.N.6
Atkin, S.L.7
-
28
-
-
0031975052
-
Expression of estrogen receptor beta messenger RNA variant in breast cancer
-
Vladusic E.A., Hornby A.E., Guerra-Vladusic F.K., and Lupu R. Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res. 58 (1998) 210-214
-
(1998)
Cancer Res.
, vol.58
, pp. 210-214
-
-
Vladusic, E.A.1
Hornby, A.E.2
Guerra-Vladusic, F.K.3
Lupu, R.4
-
29
-
-
2642712522
-
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
-
Walsh B.W., Kuller L.H., Wild R.A., Paul S., Farmer M., Lawrence J.B., Shah A.S., and Anderson P.W. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 279 (1998) 1445-1451
-
(1998)
JAMA
, vol.279
, pp. 1445-1451
-
-
Walsh, B.W.1
Kuller, L.H.2
Wild, R.A.3
Paul, S.4
Farmer, M.5
Lawrence, J.B.6
Shah, A.S.7
Anderson, P.W.8
-
30
-
-
12144289305
-
Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation
-
Watanabe T., Akishita M., Nakaoka T., Kozaki K., Miyahara Y., He H., Ohike Y., Ogita T., Inoue S., Muramatsu M., Yamashita N., and Ouchi Y. Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation. Cardiovasc. Res. 59 (2003) 734-744
-
(2003)
Cardiovasc. Res.
, vol.59
, pp. 734-744
-
-
Watanabe, T.1
Akishita, M.2
Nakaoka, T.3
Kozaki, K.4
Miyahara, Y.5
He, H.6
Ohike, Y.7
Ogita, T.8
Inoue, S.9
Muramatsu, M.10
Yamashita, N.11
Ouchi, Y.12
-
31
-
-
77957126077
-
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions(PEPI) trial
-
Writing Group for the PEPI Trial
-
Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions(PEPI) trial. JAMA 273 (1995) 199-208
-
(1995)
JAMA
, vol.273
, pp. 199-208
-
-
-
32
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
-
Writing Group for the Women's Health Initiative Investigators
-
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
33
-
-
33750586484
-
Effects of selective estrogen receptor modulators Raloxifene in aorta and gland of female experimental atherosclerosis rabbits and possible involvement of ERK signal transduction pathway
-
Xiang Q.L., Chen Y., Lin G.P., Tan Z., and Huang T.H. Effects of selective estrogen receptor modulators Raloxifene in aorta and gland of female experimental atherosclerosis rabbits and possible involvement of ERK signal transduction pathway. Chin. J. Physiol. 49 (2006) 132-140
-
(2006)
Chin. J. Physiol.
, vol.49
, pp. 132-140
-
-
Xiang, Q.L.1
Chen, Y.2
Lin, G.P.3
Tan, Z.4
Huang, T.H.5
-
34
-
-
0029841146
-
Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene
-
Yang N.N., Venugopalan M., Hardikar S., and Glasebrook A. Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. Science 273 (1996) 1222-1225
-
(1996)
Science
, vol.273
, pp. 1222-1225
-
-
Yang, N.N.1
Venugopalan, M.2
Hardikar, S.3
Glasebrook, A.4
-
35
-
-
0029069540
-
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
-
Yu C.L., Meyer D.J., Campbell G.S., Larner A.C., Carter-Su C., Schwartz J., and Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269 (1995) 81-83
-
(1995)
Science
, vol.269
, pp. 81-83
-
-
Yu, C.L.1
Meyer, D.J.2
Campbell, G.S.3
Larner, A.C.4
Carter-Su, C.5
Schwartz, J.6
Jove, R.7
|